Â鶹ÊÓƵ

Crunch time for healthcare trusts

Bellevue is getting creative as it fights for its life. Will it work?

The Japanese market is on a roll – use these funds to invest

The country’s recent rally is backed by a compelling long-term case, but valuations might be close to the peak

John Baron: Why I’m sticking with gold and mining trusts

Our investment trust expert explains why he’s backing precious metals despite the asset’s recent volatility

Two global investment trusts for frothy markets

A couple of sensible options for uncertain global investors

Nick Train awaits his nadir

Finsbury Growth & Income has more ground to make up after a punishing year

A novel way to take advantage of private equity

In Trump’s world, Europe looks more attractive than it used to. That also applies to its private companies

Shares I Love: Amadeus

The market is overlooking the growth capabilities of this IT company, says STS Global Income & Growth’s James Harries

Shares I Love: Ashtead

This company is well-positioned to keep gaining market share, says investment manager Metropolis

Biotech trusts regain ground after M&A revival

Following a tricky second quarter, are market conditions favouring biotechs?

‘I have £2.3mn – but am I retirement-ready?’

Portfolio Clinic: With sizeable assets, our reader wonders what else needs to be done as he considers an early retirement. Dave Baxter takes a look